checkAd

    Celularity Abstract “Emerging Technologies for the Management and Protection of Tendon Injuries  109  0 Kommentare Decellularized Placental Biomaterials” Accepted at ORS Tendon Conference 2024 - Seite 3

    Celularity Investor Contact:
    Carlos Ramirez, SVP, Investor Relations
    Celularity Inc.
    carlos.ramirez@celularity.com

    Lesen Sie auch

    Media Contact:
    Ali Nagy / Michaela Fawcett
    KCSA Strategic Communications
    anagy@kcsa.com / mfawcett@kcsa.com



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3
    Verfasst von globenewswire
    Celularity Abstract “Emerging Technologies for the Management and Protection of Tendon Injuries Decellularized Placental Biomaterials” Accepted at ORS Tendon Conference 2024 - Seite 3 FLORHAM PARK, N.J., April 18, 2024 (GLOBE NEWSWIRE) - Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, today announced that its …

    Auch bei Lesern beliebt

    Schreibe Deinen Kommentar

    Disclaimer